APO's market cap is now higher than NTB Never would have thought this would happen.
As of closing today, with the late run up in APO to $2.24, APO's market cap is now $128M. NTB's is $125M. NTB owns 70% of APO (or something like that). Leave's very little market value left for NTB's other businesses (or its $10M + in cash). About $1/share.
The market is showing no faith or interest in NTB's NKO or Neuro-biopharma.
Time for some corporate promotion, an investor's road show, an appearance on TV (like say BNN, Dr. Oz, Canada AM), a Neuro-bio spin out, ramped up sales and profits, and a clinical trials update for CaPre.
I expect all of this is on the way.